Journal of Microbiology and Biotechnology

The Korean Society for Microbiology and Biotechnology (한국미생물·생명공학회)
권호 표지
DOI QR코드

DOI QR Code

Nonstructural Protein of Severe Fever with Thrombocytopenia Syndrome Phlebovirus Inhibits TBK1 to Evade Interferon-Mediated Response

  • Lee, Jae Kyung (BK21 Graduate program, Department of Biomedical Sciences, Korea University College of Medicine) ;
  • Shin, Ok Sarah (BK21 Graduate program, Department of Biomedical Sciences, Korea University College of Medicine)
  • Received : 2020.08.24
  • Accepted : 2020.12.28
  • Published : 2021.02.28
Download PDF
⟨ Previous Next ⟩

Abstract

Severe fever with thrombocytopenia syndrome virus (SFTSV) is an emerging phlebovirus of the Phenuiviridae family that has been circulating in the following Asian countries: Vietnam, Myanmar, Taiwan, China, Japan, and South Korea. Despite the increasing infection rates and relatively high mortality rate, there is limited information available regarding SFTSV pathogenesis. In addition, there are currently no vaccines or effective antiviral treatments available. Previous reports have shown that SFTSV suppresses the host immune response and its nonstructural proteins (NSs) function as an antagonist of type I interferon (IFN), whose induction is an essential part of the host defense system against viral infections. Given that SFTSV NSs suppress the innate immune response by inhibiting type I IFN, we investigated the mechanism utilized by SFTSV NSs to evade IFNmediated response. Our co-immunoprecipitation data suggest the interactions between NSs and retinoic acid inducible gene-I (RIG-I) or TANK binding kinase 1 (TBK1). Furthermore, confocal analysis indicates the ability of NSs to sequester RIG-I and related downstream molecules in the cytoplasmic structures called inclusion bodies (IBs). NSs are also capable of inhibiting TBK1-interferon regulatory factor 3 (IRF3) interaction, and therefore prevent the phosphorylation and nuclear translocation of IRF3 for the induction of type I IFN. The ability of SFTSV NSs to interact with and sequester TBK1 and IRF3 in IBs demonstrate an effective yet unique method utilized by SFTSV to evade and suppress host immunity.

Keywords

References

  1. Tran XC, Yun Y, Le Van An S-HK, Thao NTP, Man PKC, Yoo JR, et al. 2019. Endemic severe fever with thrombocytopenia syndrome, Vietnam. Emerg. Infect. Dis. 25: 1029-1031. https://doi.org/10.3201/eid2505.181463
  2. Win AM, Nguyen YTH, Kim Y, Ha N-Y, Kang J-G, Kim H, et al. 2020. Genotypic heterogeneity of Orientia tsutsugamushi in scrub typhus patients and thrombocytopenia syndrome co-infection, Myanmar. Emerg. Infect. Dis. 26: 1878-1881. https://doi.org/10.3201/eid2608.200135
  3. Lin T-L, Ou S-C, Maeda K, Shimoda H, Chan JP-W, Tu W-C, et al. 2020. The first discovery of severe fever with thrombocytopenia syndrome virus in Taiwan. Emerg. Microb. Infect. 9: 148-151. https://doi.org/10.1080/22221751.2019.1710436
  4. Kim K-H, Yi J, Kim G, Choi SJ, Jun KI, Kim N-H, et al. 2013. Severe fever with thrombocytopenia syndrome, South Korea, 2012. Emerg. Infect. Dis. 19: 1892-1894.
  5. Yu X-J, Liang M-F, Zhang S-Y, Liu Y, Li J-D, Sun Y-L, et al. 2011. Fever with thrombocytopenia associated with a novel bunyavirus in China. N. Engl. J. Med. 364: 1523-1532. https://doi.org/10.1056/NEJMoa1010095
  6. Zhang Y-Z, Zhou D-J, Qin X-C, Tian J-H, Xiong Y, Wang J-B, et al. 2012. The ecology, genetic diversity, and phylogeny of Huaiyangshan virus in China. J. Virol. 86: 2864-2868. https://doi.org/10.1128/JVI.06192-11
  7. Yu X-J, Liang M-F, Zhang S-Y, Liu Y, Li J-D, Sun Y-L, et al. 2011. Fever with thrombocytopenia associated with a novel bunyavirus in China. N. Engl. J. Med. 364: 1523-1532. https://doi.org/10.1056/NEJMoa1010095
  8. Yun S-M, Lee W-G, Ryou J, Yang S-C, Park S-W, Roh JY, et al. 2014. Severe fever with thrombocytopenia syndrome virus in ticks collected from humans, South Korea, 2013. Emerg. Infect. Dis. 20: 1358-1361. https://doi.org/10.3201/eid2008.131857
  9. Zhuang L, Sun Y, Cui X-M, Tang F, Hu J-G, Wang L-Y, et al. 2018. Transmission of severe fever with thrombocytopenia syndrome virus by Haemaphysalis longicornis ticks, China. Emerg. Infect. Dis. 24: 868-871. https://doi.org/10.3201/eid2405.151435
  10. Chen C, Li P, Li K-F, Wang H-L, Dai Y-X, Cheng X, et al. 2019. Animals as amplification hosts in the spread of severe fever with thrombocytopenia syndrome virus: a systematic review and meta-analysis. Int. J. Infect. Dis. 79: 77-84.
  11. Niu G, Li J, Liang M, Jiang X, Jiang M, Yin H, et al. 2013. Severe fever with thrombocytopenia syndrome virus among domesticated animals, China. Emerg. Infect. Dis. 19: 756-763.
  12. Jiang X, Zhang S, Jiang M, Bi Z, Liang M, Ding S, et al. 2015. A cluster of person-to-person transmission cases caused by SFTS virus in Penglai, China. Clin. Microbiol. Infect. 21: 274-279. https://doi.org/10.1016/j.cmi.2014.10.006
  13. Matsuno K, Feldmann H, Ebihara H. 2014. Severe fever with thrombocytopenia syndrome associated with a novel bunyavirus, pp. 1-12. Emerg. Infect. Dis. Ed. Elsevier
  14. Liu Q, He B, Huang S-Y, Wei F, Zhu X-Q. 2014. Severe fever with thrombocytopenia syndrome, an emerging tick-borne zoonosis. Lancet Infect. Dis. 14: 763-772. https://doi.org/10.1016/S1473-3099(14)70718-2
  15. Dong F, Li D, Wen D, Li S, Zhao C, Qi Y, et al. 2019. Single dose of a rVSV-based vaccine elicits complete protection against severe fever with thrombocytopenia syndrome virus. NPJ Vaccines 4: 5. https://doi.org/10.1038/s41541-018-0096-y
  16. Chow KT, Gale M, Jr., Loo YM. 2018. RIG-I and Other RNA Sensors in Antiviral Immunity. Annu. Rev. Immunol. 36: 667-694. https://doi.org/10.1146/annurev-immunol-042617-053309
  17. Yoneyama M, Kikuchi M, Natsukawa T, Shinobu N, Imaizumi T, Miyagishi M, et al. 2004. The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat. Immunol. 5: 730-737. https://doi.org/10.1038/ni1087
  18. Seth RB, Sun L, Ea C-K, Chen ZJ. 2005. Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-κB and IRF3. Cell 122: 669-682. https://doi.org/10.1016/j.cell.2005.08.012
  19. Hong Y, Bai M, Qi X, Li C, Liang M, Li D, et al. 2019. Suppression of the IFN-α and-β induction through sequestering IRF7 into viral inclusion bodies by nonstructural protein NSs in severe fever with thrombocytopenia syndrome bunyavirus infection. J. Immunol. 202: 841-856. https://doi.org/10.4049/jimmunol.1800576
  20. Ning Y-J, Feng K, Min Y-Q, Cao W-C, Wang M, Deng F, et al. 2015. Disruption of type I interferon signaling by the nonstructural protein of severe fever with thrombocytopenia syndrome virus via the hijacking of STAT2 and STAT1 into inclusion bodies. J. Virol. 89: 4227-4236. https://doi.org/10.1128/JVI.00154-15
  21. Chaudhary V, Zhang S, Yuen K-S, Li C, Lui P-Y, Fung S-Y, et al. 2015. Suppression of type I and type III IFN signalling by NSs protein of severe fever with thrombocytopenia syndrome virus through inhibition of STAT1 phosphorylation and activation. J. Gen. Virol. 96: 3204-3211. https://doi.org/10.1099/jgv.0.000280
  22. Kitagawa Y, Sakai M, Shimojima M, Saijo M, Itoh M, Gotoh B. 2018. Nonstructural protein of severe fever with thrombocytopenia syndrome phlebovirus targets STAT2 and not STAT1 to inhibit type I interferon-stimulated JAK-STAT signaling. Microbes Infect. 20: 360-368. https://doi.org/10.1016/j.micinf.2018.05.007
  23. Moriyama M, Igarashi M, Koshiba T, Irie T, Takada A, Ichinohe T. 2018. Two conserved amino acids within the NSs of severe fever with thrombocytopenia syndrome phlebovirus are essential for anti-interferon activity. J. Virol. 92: e00706.
  24. Seong RK, Lee JK, Shin OS. 2020. Zika Virus-induction of the suppressor of cytokine signaling 1/3 contributes to the modulation of viral replication. Pathogens 9: 163. https://doi.org/10.3390/pathogens9030163
  25. Kim JA, Seong RK, Son SW, Shin OS. 2019. Insights into ZIKV-Mediated Innate Immune Responses in Human Dermal Fibroblasts and Epidermal Keratinocytes. J. Invest Dermatol. 139: 391-399. https://doi.org/10.1016/j.jid.2018.07.038
  26. Knowlton KU, Jeon ES, Berkley N, Wessely R, Huber S. 1996. A mutation in the puff region of VP2 attenuates the myocarditic phenotype of an infectious cDNA of the Woodruff variant of coxsackievirus B3. J. Virol. 70: 7811-7818. https://doi.org/10.1128/jvi.70.11.7811-7818.1996
  27. Oh SJ, Gim JA, Lee JK, Park H, Shin OS. 2020. Coxsackievirus B3 Infection of human neural progenitor cells results in distinct expression patterns of innate immune genes. Viruses 12: 325. https://doi.org/10.3390/v12030325
  28. Servant MJ, ten Oever B, LePage C, Conti L, Gessani S, Julkunen I, et al. 2001. Identification of distinct signaling pathways leading to the phosphorylation of interferon regulatory factor 3. J. Biol. Chem. 276: 355-363. https://doi.org/10.1074/jbc.M007790200
  29. Tam PE. 2006. Coxsackievirus myocarditis: interplay between virus and host in the pathogenesis of heart disease. Viral Immunol. 19: 133-146. https://doi.org/10.1089/vim.2006.19.133
  30. Yadani F-Z, Kohl A, Prehaud C, Billecocq A, Bouloy M. 1999. The carboxy-terminal acidic domain of Rift Valley Fever virus NSs protein is essential for the formation of filamentous structures but not for the nuclear localization of the protein. J. Virol. 73: 5018-5025. https://doi.org/10.1128/jvi.73.6.5018-5025.1999
  31. Billecocq A, Spiegel M, Vialat P, Kohl A, Weber F, Bouloy M, et al. 2004. NSs protein of Rift Valley fever virus blocks interferon production by inhibiting host gene transcription. J. Virol. 78: 9798-9806. https://doi.org/10.1128/JVI.78.18.9798-9806.2004
  32. Savellini GG, Weber F, Terrosi C, Habjan M, Martorelli B, Cusi MG. 2011. Toscana virus induces interferon although its NSs protein reveals antagonistic activity. J. Gen. Virol. 92: 71-79. https://doi.org/10.1099/vir.0.025999-0
  33. Bridgen A, Weber F, Fazakerley JK, Elliott RM. 2001. Bunyamwera bunyavirus nonstructural protein NSs is a nonessential gene product that contributes to viral pathogenesis. Proc. Natl. Acad. Sci. USA 98: 664-669. https://doi.org/10.1073/pnas.98.2.664
  34. Weber F, Bridgen A, Fazakerley JK, Streitenfeld H, Kessler N, Randall RE, et al. 2002. Bunyamwera bunyavirus nonstructural protein NSs counteracts the induction of alpha/beta interferon. J. Virol. 76: 7949-7955. https://doi.org/10.1128/JVI.76.16.7949-7955.2002
  35. Blakqori G, Delhaye S, Habjan M, Blair CD, Sanchez-Vargas I, Olson KE, et al. 2007. La Crosse bunyavirus nonstructural protein NSs serves to suppress the type I interferon system of mammalian hosts. J. Virol. 81: 4991-4999. https://doi.org/10.1128/JVI.01933-06
  36. Leonard VH, Kohl A, Hart TJ, Elliott RM. 2006. Interaction of Bunyamwera Orthobunyavirus NSs protein with mediator protein MED8: a mechanism for inhibiting the interferon response. J. Virol. 80: 9667-9675. https://doi.org/10.1128/JVI.00822-06
  37. Rincheval V, Lelek M, Gault E, Bouillier C, Sitterlin D, Blouquit-Laye S, et al. 2017. Functional organization of cytoplasmic inclusion bodies in cells infected by respiratory syncytial virus. Nat. Commun. 8: 563. https://doi.org/10.1038/s41467-017-00655-9
  38. Novoa RR, Calderita G, Arranz R, Fontana J, Granzow H, Risco C. 2005. Virus factories: associations of cell organelles for viral replication and morphogenesis. Biol. Cell 97: 147-172. https://doi.org/10.1042/BC20040058
  39. Le Negrate G. 2012. Viral interference with innate immunity by preventing NF‐κB activity. Cell. Microbiol. 14: 168-181. https://doi.org/10.1111/j.1462-5822.2011.01720.x
  40. Choi Y, Park SJ, Sun Y, Yoo JS, Pudupakam RS, Foo SS, et al. 2019. Severe fever with thrombocytopenia syndrome phlebovirus non-structural protein activates TPL2 signalling pathway for viral immunopathogenesis. Nat. Microbiol. 4: 429-437. https://doi.org/10.1038/s41564-018-0329-x
  41. Ning Y-J, Feng K, Min Y-Q, Deng F, Hu Z, Wang H. 2017. Heartland virus NSs protein disrupts host defenses by blocking the TBK1 kinase-IRF3 transcription factor interaction and signaling required for interferon induction. J. Biol. Chem. 292: 16722-16733. https://doi.org/10.1074/jbc.M117.805127
  42. Liu Y, Wu B, Paessler S, Walker DH, Tesh RB, Yu X-j. 2014. The pathogenesis of severe fever with thrombocytopenia syndrome virus infection in alpha/beta interferon knockout mice: insights into the pathologic mechanisms of a new viral hemorrhagic fever. J. Virol. 88: 1781-1786. https://doi.org/10.1128/JVI.02277-13
  43. Yamada S, Shimojima M, Narita R, Tsukamoto Y, Kato H, Saijo M, et al. 2018. RIG-I-like receptor and Toll-like receptor signaling pathways cause aberrant production of inflammatory cytokines/chemokines in a severe fever with thrombocytopenia syndrome virus infection mouse model. J. Virol. 92: e2246-17.
  44. Park SJ, Kim YI, Park A, Kwon HI, Kim EH, Si YJ, et al. 2019. Ferret animal model of severe fever with thrombocytopenia syndrome phlebovirus for human lethal infection and pathogenesis. Nat. Microbiol. 4: 438-446. https://doi.org/10.1038/s41564-018-0317-1
  45. Oh S-J, Lee JK, Shin OS. 2019. Aging and the immune system: the impact of immunosenescence on viral infection, immunity and vaccine immunogenicity. J. Immune Netw. 19: e37. https://doi.org/10.4110/in.2019.19.e37
  46. Zhang L, Fu Y, Wang H, Guan Y, Zhu W, Guo M, et al. 2019. Severe fever with thrombocytopenia syndrome virus infection drives macrophage differentiation skewed to M2 phenotype which is regulated by miR-146. Front. Immunol. 10: 1095. https://doi.org/10.3389/fimmu.2019.01095

Cited by

  1. SAFA initiates innate immunity against cytoplasmic RNA virus SFTSV infection vol.17, pp.11, 2021, https://doi.org/10.1371/journal.ppat.1010070